Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs

Abstract

The pharmaceutical sector has made considerable strides recently, emphasizing improving drug delivery methods to increase the bioavailability of various drugs. When used as a medication delivery method, nanoemulsions have multiple benefits. Their small droplet size, which is generally between 20 and 200 nanometers, creates a significant interfacial area for drug dissolution, improving the solubility and bioavailability of drugs that are weakly water-soluble. Additionally, nanoemulsions are a flexible platform for drug administration across various therapeutic areas since they can encapsulate hydrophilic and hydrophobic medicines. Nanoemulsion can be formulated in multiple dosage forms, for example, gels, creams, foams, aerosols, and sprays by using low-cost standard operative processes and also be taken orally, topically, topically, intravenously, intrapulmonary, intranasally, and intraocularly. The article explores nanoemulsion formulation and production methods, emphasizing the role of surfactants and cosurfactants in creating stable formulations. In order to customize nanoemulsions to particular medication delivery requirements, the choice of components and production techniques is crucial in assuring the stability and efficacy of the finished product. Nanoemulsions are a cutting-edge technology with a lot of potential for improving medication bioavailability in a variety of therapeutic contexts. They are a useful tool in the creation of innovative pharmaceutical formulations due to their capacity to enhance drug solubility, stability, and delivery. Nanoemulsions are positioned to play a crucial role in boosting medication delivery and enhancing patient outcomes as this field of study continues to advance.

References 151

1. 1.

   Mason T. G., Wilking J. N., Meleson K., Chang C. B., Graves S. M. Nanoemulsions: formation, structure, and physical properties. Journal of Physics: Condensed Matter. 2006;18:R635-R666.

   Not in our library10.1088/0953-8984/18/41/r01 (opens in a new tab)

2. 2.

   Ee S. L., Duan X., Liew J., Nguyen Q. D. Droplet size and stability of nano-emulsions produced by the temperature phase inversion method. Chemical Engineering Journal. 2008;140(1-3):626-631.

   Not in our library10.1016/j.cej.2007.12.016 (opens in a new tab)

3. 3.

   McClements D. J. Nanoemulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticals. Therapeutic Delivery. 2013;4(7):841-857.

   Not in our library10.4155/tde.13.46 (opens in a new tab)

4. 4.

   Lee S. J., Choi S. J., Li Y., Decker E. A., McClements D. J. Protein-stabilized nanoemulsions and emulsions: comparison of physicochemical stability, lipid oxidation, and lipase digestibility. Journal of Agricultural and Food Chemistry. 2011;59(1):415-427.

   Not in our library10.1021/jf103511v (opens in a new tab)

5. 5.

   Bouchemal K., Briançon S., Perrier E., Fessi H. Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. International Journal of Pharmaceutics. 2004;280(1-2):241-251.

   Not in our library10.1016/j.ijpharm.2004.05.016 (opens in a new tab)

6. 6.

   Yu H., Huang Q. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. Journal of Agricultural and Food Chemistry. 2012;60(21):5373-5379.

   Not in our library10.1021/jf300609p (opens in a new tab)

7. 7.

   Zhang Y., Shang Z., Gao C., et al. Nanoemulsion for solubilization, stabilization, and in vitro release of pterostilbene for oral delivery. AAPS PharmSciTech. 2014;15(4):1000-1008.

   Not in our library10.1208/s12249-014-0129-4 (opens in a new tab)

8. 8.

   Yukuyama M. N., Ghisleni D. D. M., Pinto T. J. A., Bou‐Chacra N. A. Nanoemulsion: process selection and application in cosmetics– a review. International Journal of Cosmetic Science. 2016;38(1):13-24.

   Not in our library10.1111/ics.12260 (opens in a new tab)

9. 9.

   Wang L., Li X., Zhang G., Dong J., Eastoe J. Oil-in-water nanoemulsions for pesticide formulations. Journal of Colloid and Interface Science. 2007;314(1):230-235.

   Not in our library10.1016/j.jcis.2007.04.079 (opens in a new tab)

10. 10.

    Tan S., Stanslas J., Basri M., et al. Nanoemulsion-based parenteral drug delivery system of carbamazepine: preparation, characterization, stability evaluation and blood-brain pharmacokinetics. Current Drug Delivery. 2015;12(6):795-804.

    Not in our library10.2174/1567201812666150901112544 (opens in a new tab)

11. 11.

    Sharma N., Mishra S., Sharma S., Deshpande R. D., Sharma R. K. Preparation and optimization of nanoemulsions for targeting drug delivery. International Journal of Drug Development and Research. 2013;5(4):37-48.

    Not in our library

12. 12.

    Al-Edresi S., Baie S. Formulation and stability of whitening VCO-in-waternano-cream. International Journal of Pharmaceutics. 2009;373(1-2):174-178.

    Not in our library10.1016/j.ijpharm.2009.02.011 (opens in a new tab)

13. 13.

    Makidon P. E., Nigavekar S. S., Bielinska A. U., et al. Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2010;23(2):77-89.

    Not in our library10.1089/jamp.2009.0766 (opens in a new tab)

14. 14.

    Lala R. R., Awari N. G. Nanoemulsion-based gel formulations of COX-2 inhibitors for enhanced efficacy in inflammatory conditions. Applied Nanoscience. 2014;4(2):143-151.

    Not in our library10.1007/s13204-012-0177-6 (opens in a new tab)

15. 15.

    Hussain A., Samad A., Singh S. K., et al. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Delivery. 2016;23(2):642-657.

    Not in our library10.3109/10717544.2014.933284 (opens in a new tab)

16. 16.

    Nasr M., Nawaz S., Elhissi A. Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. International Journal of Pharmaceutics. 2012;436(1-2):611-616.

    Not in our library10.1016/j.ijpharm.2012.07.028 (opens in a new tab)

17. 17.

    Amani A., York P., Chrystyn H., Clark B. J. Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. AAPS PharmSciTech. 2010;11(3):1147-1151.

    Not in our library10.1208/s12249-010-9486-9 (opens in a new tab)

18. 18.

    Tamarkin D., Besonov A., Eini M., Danziger J. Foam prepared from nanoemulsions and uses. 2007.

    Not in our library

19. 19.

    Mou D., Chen H., Du D., et al. Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. International Journal of Pharmaceutics. 2008;353(1-2):270-276.

    Not in our library10.1016/j.ijpharm.2007.11.051 (opens in a new tab)

20. 20.

    Khani S., Keyhanfar F., Amani A. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Delivery. 2016;23(6):2035-2043.

    Not in our library10.3109/10717544.2015.1088597 (opens in a new tab)

21. 21.

    Pawar V. K., Panchal S. B., Singh Y., et al. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response. Journal of Controlled Release. 2014;196:295-306.

    Not in our library10.1016/j.jconrel.2014.10.010 (opens in a new tab)

22. 22.

    Bhanushali R. S., Gatne M. M., Gaikwad R. V., Bajaj A. N., Morde M. A. Nanoemulsion based intranasal delivery of antimigraine drugs for nose to brain targeting. Indian Journal of Pharmaceutical Sciences. 2009;71(6):p. 707.

    Not in our library

23. 23.

    Ammar H. O., Salama H. A., Ghorab M., Mahmoud A. A. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech. 2009;10(3):808-819.

    Not in our library10.1208/s12249-009-9268-4 (opens in a new tab)

24. 24.

    Khan A. A., Mudassir J., Mohtar N., Darwis Y. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. International Journal of Nanomedicine. 2013;8:2733-2744.

    Not in our library10.2147/ijn.s41521 (opens in a new tab)

25. 25.

    Garti N., Frenkel M., Shwartz R. Multiple emulsions. Part II: proposed technique to overcome unpleasant taste of drugs. Journal of Dispersion Science Andtechnology. 1983;4(3):237-252.

    Not in our library10.1080/01932698308943369 (opens in a new tab)

26. 26.

    Singh Y., Meher J. G., Raval K., et al. Nanoemulsion: concepts, development and applications in drug delivery. Journal of Controlled Release. 2017;252:28-49.

    Not in our library10.1016/j.jconrel.2017.03.008 (opens in a new tab)

27. 27.

    Karasulu H. Y. Microemulsions as novel drug carriers: the formation, stability, applications and toxicity. Expert Opinion on Drug Delivery. 2008;5(1):119-135.

    Not in our library10.1517/17425247.5.1.119 (opens in a new tab)

28. 28.

    Schulman J. H., Stoeckenius W., Prince L. M. Mechanism of formation and structure of micro emulsions by electron microscopy. Journal of Physical Chemistry. 1959;63(10):1677-1680.

    Not in our library10.1021/j150580a027 (opens in a new tab)

29. 29.

    Pouton C. W., Porter C. J. H. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Advanced Drug Delivery Reviews. 2008;60(6):625-637.

    Not in our library10.1016/j.addr.2007.10.010 (opens in a new tab)

30. 30.

    Singh B., Bandopadhyay S., Kapil R., Singh R., Katare O. P. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Critical Reviews in Therapeutic Drug Carrier Systems. 2009;26:427-451.

    Not in our library10.1615/critrevtherdrugcarriersyst.v26.i5.10 (opens in a new tab)

31. 31.

    Ghosh V., Mukherjee A., Chandrasekaran N. Eugenol-loaded antimicrobial nanoemulsion preserves fruit juice against, microbial spoilage. Colloids and Surfaces B: Biointerfaces. 2014;114:392-397.

    Not in our library10.1016/j.colsurfb.2013.10.034 (opens in a new tab)

32. 32.
    Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments · 2011

    No notice
33. 33.

    Vyas T. K., Shahiwala A., Amiji M. M. Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. International Journal of Pharmaceutics. 2008;347(1-2):93-101.

    Not in our library10.1016/j.ijpharm.2007.06.016 (opens in a new tab)

34. 34.

    Jiang S. P., He S.-N., Li Y.-L., et al. Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin. International Journal of Nanomedicine. 2013;8:3141-3150.

    Not in our library10.2147/ijn.s47708 (opens in a new tab)

35. 35.

    Anuchapreeda S., Fukumori Y., Okonogi S., Ichikawa H. Preparation of lipid nanoemulsions incorporating curcumin for cancer therapy. Journal of nanotechnology. 2012;2012:11.

    Not in our library10.1155/2012/270383 (opens in a new tab)

36. 36.

    Hwang Y. Y., Ramalingam K., Bienek D. R., Lee V., You T., Alvarez R. Antimicrobial activity of nanoemulsion in combination with cetylpyridinium chloride in multidrug-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 2013;57(8):3568-3575.

    Not in our library10.1128/aac.02109-12 (opens in a new tab)

37. 37.

    Abd-Elsalam K. A., Khokhlov A. R. Eugenol oil nanoemulsion: antifungal activity against Fusarium oxysporum f. sp. vasinfectum and phytotoxicity on cottonseeds. Applied Nanoscience. 2015;5(2):255-265.

    Not in our library10.1007/s13204-014-0398-y (opens in a new tab)

38. 38.

    Ozturk B., Argin S., Ozilgen M., McClements D. J. Formation and stabilization of nanoemulsion-based vitamin E delivery systems using natural biopolymers: whey protein isolate and gum Arabic. Food Chemistry. 2015;188:256-263.

    Not in our library10.1016/j.foodchem.2015.05.005 (opens in a new tab)

39. 39.

    Morais Diane J. M., Burgess J. Vitamin E nanoemulsions characterization and analysis. International Journal of Pharmaceutics. 2014;465(1-2):455-463.

    Not in our library10.1016/j.ijpharm.2014.02.034 (opens in a new tab)

40. 40.
    Nanoemulsion: an advanced mode of drug delivery system · 2014

    No notice
41. 41.

    Amselem S., Friedman D. Submicron emulsions as drug carriers for topical administration. Submicron Emulsions in Drug Targeting and Delivery. 2019;153-174.

    Not in our library

42. 42.

    Shakeel F., Baboota S., Ahuja A., Ali J., Aqil M., Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech. 2007;8(4):191-199.

    Not in our library10.1208/pt0804104 (opens in a new tab)

43. 43.

    Shrestha H., Bala R., Arora S. Lipid-based drug delivery systems. Journal of pharmaceutics. 2014;2014:10.

    Not in our library10.1155/2014/801820 (opens in a new tab)

44. 44.

    Gibaud S., Attivi D. Microemulsions for oral administration and their therapeutic applications. Expert Opinion on Drug Delivery. 2012;9(8):937-951.

    Not in our library10.1517/17425247.2012.694865 (opens in a new tab)

45. 45.

    Neslihan Gursoy R., Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine and Pharmacotherapy. 2004;58(3):173-182.

    Not in our library10.1016/j.biopha.2004.02.001 (opens in a new tab)

46. 46.

    Fernandez P., André V., Rieger J., Kühnle A. Nano-emulsion formation by emulsion phase inversion. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2004;251(1-3):53-58.

    Not in our library10.1016/j.colsurfa.2004.09.029 (opens in a new tab)

47. 47.

    Ostertag F., Weiss J., McClements D. J. Low-energy formation of edible nanoemulsions: factors influencing droplet size produced by emulsion phase inversion. Journal of Colloid and Interface Science. 2012;388(1):95-102.

    Not in our library10.1016/j.jcis.2012.07.089 (opens in a new tab)

48. 48.

    Müller R., Müller R. H. Nanocrystal technology, drug delivery and clinical applications. International Journal of Nanomedicine. 2008;3(3):295-310.

    Not in our library10.2147/ijn.s595 (opens in a new tab)

49. 49.

    Gué E., Since M., Ropars S., Herbinet R., Le Pluart L., Malzert-Fréon A. Evaluation of the versatile character of a nanoemulsion formulation. International Journal of Pharmaceutics. 2016;498(1-2):49-65.

    Not in our library10.1016/j.ijpharm.2015.12.010 (opens in a new tab)

50. 50.

    Morsi N. M., Mohamed M. I., Refai H., El Sorogy H. Nanoemulsion as a novel ophthalmic delivery system for acetazolamide. International Journal of Pharmacy and Pharmaceutical Sciences. 2014;6(11):227-236.

    Not in our library

51. 51.

    Srilatha R., Aparna C., Srinivas P., Sadanandam M. Formulation, evaluation and characterization of glipizide nanoemulsion. Asian Journal of Pharmaceutical and Clinical Research. 2013;6(no. 2):66-71.

    Not in our library

52. 52.

    Gurpreet K., Singh S. K. Review of nanoemulsion formulation and characterization techniques. Indian Journal of Pharmaceutical Sciences. 2018;80(5):781-789.

    Not in our library

53. 53.

    Bhosale R. R., Osmani R. A., Ghodake P. P., Shaikh S. M., Chavan S. R. Nanoemulsion: a review on novel profusion in advanced drug delivery. Indian Journal of Pharmaceutical and Biological Research. 2014;2(01):122-127.

    Not in our library10.30750/ijpbr.2.1.19 (opens in a new tab)

54. 54.

    Laxmi M., Bhardwaj A., Mehta S., Mehta A. Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether. Artificial Cells, Nanomedicine, and Biotechnology. 2015;43(5):334-344.

    Not in our library10.3109/21691401.2014.887018 (opens in a new tab)

55. 55.

    Bali V., Ali M., Ali J. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. Journal of Drug Targeting. 2010;18(7):506-519.

    Not in our library10.3109/10611860903548362 (opens in a new tab)

56. 56.

    Harika K., Debnath S. Formulation and evaluation of nanoemulsion of amphotericin B. International Journal of Novel Trends in Pharmaceutical Sciences. 2015;5(4):114-122.

    Not in our library

57. 57.

    Bhagav P., Upadhyay H., Chandran S. Brimonidine tartrate–eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation. AAPS PharmSciTech. 2011;12(4):1087-1101.

    Not in our library10.1208/s12249-011-9675-1 (opens in a new tab)

58. 58.

    Singh K. K., Vingkar S. K. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. International Journal of Pharmaceutics. 2008;347(1-2):136-143.

    Not in our library10.1016/j.ijpharm.2007.06.035 (opens in a new tab)

59. 59.
    Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems · 2013

    No notice
60. 60.

    Baboota S., Shakeel F., Ahuja A., Ali J., Shafiq S. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharmaceutica. 2007;57(3):315-332.

    Not in our library10.2478/v10007-007-0025-5 (opens in a new tab)

61. 61.

    Hall J. B., Dobrovolskaia M. A., Patri A. K., McNeil S. E. Characterization of nanoparticles for therapeutics. Nanomedicine. 2007;2:789-803.

    Not in our library10.2217/17435889.2.6.789 (opens in a new tab)

62. 62.

    Bootz A., Vogel V., Schubert D., Kreuter J. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly (butyl cyanoacrylate) nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 2004;57(2):369-375.

    Not in our library10.1016/s0939-6411(03)00193-0 (opens in a new tab)

63. 63.

    Amiji M. M. Nanotechnology for Cancer Therapy. 2006.

    Not in our library

64. 64.

    Williams D. B., Carter C. B. Transmission Electron Microscopy. 2009.

    Not in our library

65. 65.

    Carlton C. E., Ferreira P. J. In situ TEM nanoindentation of nanoparticles. Micron. 2012;43(11):1134-1139.

    Not in our library10.1016/j.micron.2012.03.002 (opens in a new tab)

66. 66.

    Hinterdorfer P., Garcia-Parajo M. F., Dufrene Y. F. Single-molecule imaging of cell surfaces using near-field nanoscopy. Accounts of Chemical Research. 2012;45(3):327-336.

    Not in our library10.1021/ar2001167 (opens in a new tab)

67. 67.

    Mavrocordatos D., Pronk W., Boller M. Analysis of environmental particles by atomic force microscopy, scanning and transmission electron microscopy. Water Science and Technology. 2004;50(12):9-18.

    Not in our library10.2166/wst.2004.0690 (opens in a new tab)

68. 68.

    Picas L., Milhiet P.-E., Hernández-Borrell J. Atomic force microscopy: a versatile tool to probe the physical and chemical properties of supported membranes at the nanoscale. Chemistry and Physics of Lipids. 2012;165(8):845-860.

    Not in our library10.1016/j.chemphyslip.2012.10.005 (opens in a new tab)

69. 69.

    Parot P., Dufrêne Y. F., Hinterdorfer P., et al. Past, present and future of atomic force microscopy in life sciences and medicine. Journal of Molecular Recognition. 2007;20(6):418-431.

    Not in our library10.1002/jmr.857 (opens in a new tab)

70. 70.

    Inagaki S., Ghirlando R., Grisshammer R. Biophysical characterization of membrane proteins in nanodiscs. Methods. 2013;59(3):287-300.

    Not in our library10.1016/j.ymeth.2012.11.006 (opens in a new tab)

71. 71.

    Jiang X., Jiang J., Jin Y., Wang E., Dong S. Effect of colloidal gold size on the conformational changes of adsorbed cytochrome c: probing by circular dichroism, UV− Visible, and Infrared Spectroscopy. Biomacromolecules. 2005;6(1):46-53.

    Not in our library10.1021/bm049744l (opens in a new tab)

72. 72.

    Perevedentseva E., Cai P.-J., Chiu Y.-C., Cheng C.-L. Characterizing protein activities on the lysozyme and nanodiamond complex prepared for bio applications. Langmuir. 2011;27(3):1085-1091.

    Not in our library10.1021/la103155c (opens in a new tab)

73. 73.

    Tom R. T., Samal A. K., Sreeprasad T. S., Pradeep T. Hemoprotein bioconjugates of gold and silver nanoparticles and gold nanorods: structure− function correlations. Langmuir. 2007;23(3):1320-1325.

    Not in our library10.1021/la061150b (opens in a new tab)

74. 74.

    Hind A. R., Bhargava S. K., McKinnon A. At the solid/liquid interface: FTIR/ATR—the tool of choice. Advances in Colloid and Interface Science. 2001;93(1-3):91-114.

    Not in our library10.1016/s0001-8686(00)00079-8 (opens in a new tab)

75. 75.

    Johal M. S. Understanding Nanomaterials. 2011.

    Not in our library

76. 76.

    Bali V., Ali M., Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids and Surfaces B: Biointerfaces. 2010;76(2):410-420.

    Not in our library10.1016/j.colsurfb.2009.11.021 (opens in a new tab)

77. 77.

    Kuo F., Subramanian B., Kotyla T., Wilson T. A., Yoganathan S., Nicolosi R. J. Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties. International Journal of Pharmaceutics. 2008;363(1-2):206-213.

    Not in our library10.1016/j.ijpharm.2008.07.022 (opens in a new tab)

78. 78.

    Harwansh R. K., Patra K. C., Pareta S. K., Singh J., Rahman M. A. Nanoemulsions as vehicles for transdermal delivery of glycyrrhizin. Brazilian Journal of Pharmaceutical Sciences. 2011;47(4):769-778.

    Not in our library10.1590/s1984-82502011000400014 (opens in a new tab)

79. 79.

    Chouksey R., Jain A. K., Pandey H., Maithil A. In vivo assessment of atorvastatin nanoemulsion formulation. Bulletin of Pharmaceutical Research. 2011;1(2):10-14.

    Not in our library

80. 80.

    Sugumar S., Mukherjee A., Natarajan C. Nanoemulsion formation and characterization by spontaneous emulsification: investigation of its antibacterial effects on Listeria monocytogenes. Asian Journal of Pharmaceutics. 2015;9:p. 1.

    Not in our library

81. 81.

    Clark M., Jepson M., Hirst B. H. Exploiting M cells for drug and vaccine delivery. Advanced Drug Delivery Reviews. 2001;50(1-2):81-106.

    Not in our library10.1016/s0169-409x(01)00149-1 (opens in a new tab)

82. 82.

    Pourmadadi M., Ahmadi M., Abdouss M., et al. The synthesis and characterization of double nanoemulsion for targeted Co-Delivery of 5-fluorouracil and curcumin using pH-sensitive agarose/chitosan nanocarrier. Journal of Drug Delivery Science and Technology. 2022;70(2022).

    Not in our library10.1016/j.jddst.2021.102849 (opens in a new tab)

83. 83.

    Jang J.-H., Jeong S.-H., Lee Y.-B. Enhanced lymphatic delivery of methotrexate using W/O/W nanoemulsion: in vitro characterization and pharmacokinetic study. Pharmaceutics. 2020;12(10):p. 978.

    Not in our library10.3390/pharmaceutics12100978 (opens in a new tab)

84. 84.

    Asmawi A. A., Salim N., Ngan C. L., et al. Excipient selection and aerodynamic characterization of nebulized lipid-based nanoemulsion loaded with docetaxel for lung cancer treatment. Drug delivery and translational research. 2019;9(2):543-554.

    Not in our library10.1007/s13346-018-0526-4 (opens in a new tab)

85. 85.

    Md S., Alhakamy N. A., Alharbi W. S., et al. Development and evaluation of repurposed etoricoxib loaded nanoemulsion for improving anticancer activities against lung cancer cells. International Journal of Molecular Sciences. 2021;22(24).

    Not in our library10.3390/ijms222413284 (opens in a new tab)

86. 86.

    Khan I., Bahuguna A., Kumar P., Vivek K., Bajpai, Kang S. C. In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis. Scientific Reports. 2018;8(1):1-15.

    Not in our library10.1038/s41598-017-18644-9 (opens in a new tab)

87. 87.

    Chen L., Chen B., Deng L., et al. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor. International Journal of Pharmaceutics. 2017;534(1-2):308-315.

    Not in our library10.1016/j.ijpharm.2017.10.005 (opens in a new tab)

88. 88.

    Samadi A., Pourmadadi M., Yazdian F., Rashedi H., Navaei-Nigjeh M., Eufrasio-da-silva T. Ameliorating quercetin constraints in cancer therapy with pH-responsive agarose-polyvinylpyrrolidone-hydroxyapatite nanocomposite encapsulated in double nanoemulsion. International Journal of Biological Macromolecules. 2021;182(2021):11-25.

    Not in our library10.1016/j.ijbiomac.2021.03.146 (opens in a new tab)

89. 89.

    Fofaria N. M., Qhattal H. S. S., Liu X., Srivastava S. K. Nanoemulsion formulations for anti-cancer agent piplartine—characterization, toxicological, pharmacokinetics and efficacy studies. International Journal of Pharmaceutics. 2016;498(1-2):12-22.

    Not in our library10.1016/j.ijpharm.2015.11.045 (opens in a new tab)

90. 90.

    Qhattal H. S. S., Wang S., Salihima T., Srivastava S. K., Liu X. Nanoemulsions of cancer chemopreventive agent benzyl isothiocyanate display enhanced solubility, dissolution, and permeability. Journal of Agricultural and Food Chemistry. 2011;59(23):12396-12404.

    Not in our library10.1021/jf202612b (opens in a new tab)

91. 91.

    D’Angelo N. A., Noronha M. A., Câmara M. C., et al. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years. Biomaterials Advances. 2022;133(2022).

    Not in our library10.1016/j.msec.2021.112623 (opens in a new tab)

92. 92.

    Haung H.-Y., Wang Y.-C., Cheng Y.-C., et al. A novel oral astaxanthin nanoemulsion from Haematococcus pluvialis induces apoptosis in lung metastatic melanoma. Oxidative Medicine and Cellular Longevity. 2020;2020:13.

    Not in our library10.1155/2020/2647670 (opens in a new tab)

93. 93.

    Bala V., Rao S., Boyd B. J., Prestidge C. A. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. Journal of Controlled Release. 2013;172(1):48-61.

    Not in our library10.1016/j.jconrel.2013.07.022 (opens in a new tab)

94. 94.

    Deng S., Iscaro A., Zambito G., et al. Development of a new hyaluronic acid based redox-responsive nanohydrogel for the encapsulation of oncolytic viruses for cancer immunotherapy. Nanomaterials. 2021;11(1):p. 144.

    Not in our library10.3390/nano11010144 (opens in a new tab)

95. 95.

    Lin Y.-H., Wang C.-C., Lin Y.-H., Chen B.-H. Preparation of catechin nanoemulsion from oolong tea leaf waste and its inhibition of prostate cancer cells DU-145 and tumors in mice. Molecules. 2021;26(11):p. 3260.

    Not in our library10.3390/molecules26113260 (opens in a new tab)

96. 96.
    Anticancer activity of Zingiber ottensii essential oil and its nanoformulations. · 2022

    Not checked
97. 97.

    Sun L., Wan K., Hu X., et al. Functional nanoemulsion-hybrid lipid nanocarriers enhance the bioavailability and anti-cancer activity of lipophilic diferuloylmethane. Nanotechnology. 2016;27(8).

    Not in our library10.1088/0957-4484/27/8/085102 (opens in a new tab)

98. 98.

    Yousefian Rad E., Homayouni Tabrizi M., Ardalan P., et al. Citrus lemon essential oil nanoemulsion (CLEO-NE), a safe cell-depended apoptosis inducer in human A549 lung cancer cells with anti-angiogenic activity. Journal of Microencapsulation. 2020;37(5):394-402.

    Not in our library10.1080/02652048.2020.1767223 (opens in a new tab)

99. 99.
    Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin · 2018

    Not checked
100. 100.

     Lucas S. R. R., Maranhão R. C., Guerra J. L., Coelho B. M. P., Barboza R., Pozzi D. H. B. Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma. Veterinary and Comparative Oncology. 2015;13(3):184-193.

     Not in our library10.1111/vco.12033 (opens in a new tab)

101. 101.

     Jha S. K., Han H. S., Subedi L., et al. Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative–lipid complex. Drug Delivery. 2020;27(1):1501-1513.

     Not in our library10.1080/10717544.2020.1837293 (opens in a new tab)

102. 102.

     Melancon M. P., Yevich S., Avritscher R., et al. A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver. Drug Delivery. 2021;28(1):240-251.

     Not in our library10.1080/10717544.2020.1869863 (opens in a new tab)

103. 103.

     Galdino de Souza D., Santos D. S., Simon K. S., et al. Fish oil nanoemulsion supplementation attenuates bleomycin-induced pulmonary fibrosis BALB/c mice. Nanomaterials. 2022;12(10):p. 1683.

     Not in our library10.3390/nano12101683 (opens in a new tab)

104. 104.

     Ganta S., Sharma P., Paxton J. W., Baguley B. C., Garg S. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion. Journal of Drug Targeting. 2010;18(2):125-133.

     Not in our library10.3109/10611860903244199 (opens in a new tab)

105. 105.

     Vernazza S., Dellacasa E., Tirendi S., Pastorino L., Bassi A. M. Lipoperoxide nanoemulsion as adjuvant in cisplatin cancer therapy: in vitro study on human colon adenocarcinoma DLD-1 cells. Nanomaterials. 2021;11(6):p. 1365.

     Not in our library10.3390/nano11061365 (opens in a new tab)

106. 106.

     Choi J. U., Maharjan R., Pangeni R., et al. Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion. Journal of Controlled Release. 2020;322:13-30.

     Not in our library10.1016/j.jconrel.2020.03.012 (opens in a new tab)

107. 107.

     Kumar D., Aqil M., Rizwan M., Sultana Y., Ali M. Investigation of a nanoemulsion as vehicle for transdermal delivery of amlodipine. Die Pharmazie. 2009;64(2):80-85.

     Not in our library

108. 108.

     Chhabra G., Chuttani K., Mishra A. K., Pathak K. Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Development and Industrial Pharmacy. 2011;37(8):907-916.

     Not in our library10.3109/03639045.2010.550050 (opens in a new tab)

109. 109.

     Ghareeb M. M. Formulation and characterization of isradipine as oral nanoemulsion. Iraqi Journal of Pharmaceutical Sciences. 2020;29(1):143-153.

     Not in our library

110. 110.

     Sharma A., Singh A. P., Harikumar S. L. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design. Drug Development and Industrial Pharmacy. 2020;46(2):329-342.

     Not in our library10.1080/03639045.2020.1721527 (opens in a new tab)

111. 111.

     Rachmawati H., Soraya I. S., Kurniati N. F., Rahma A. In vitro study on antihypertensive and antihypercholesterolemic effects of curcumin nanoemulsion. Scientia Pharmaceutica. 2016;84(1):131-140.

     Not in our library10.3797/scipharm.isp.2015.05 (opens in a new tab)

112. 112.

     Malkawi A., Jalil A., Nazir I., Matuszczak B., Kennedy R., Bernkop-Schnürch A. Self-emulsifying drug delivery systems: hydrophobic drug polymer complexes provide a sustained release in vitro. Molecular Pharmaceutics. 2020;17(10):3709-3719.

     Not in our library10.1021/acs.molpharmaceut.0c00389 (opens in a new tab)

113. 113.

     Shafiq S., Shakeel F. Enhanced stability of ramipril in nanoemulsion containing cremophor-EL: a technical note. AAPS PharmSciTech. 2008;9(4):1097-1101.

     Not in our library10.1208/s12249-008-9151-8 (opens in a new tab)

114. 114.

     Ekambaram P., Abdul Hasan Sathali A. Formulation and evaluation of solid lipid nanoparticles of ramipril. Journal of Young Pharmacists. 2011;3(3):216-220.

     Not in our library10.4103/0975-1483.83765 (opens in a new tab)

115. 115.

     Zhang Z., Gao F., Bu H., Xiao J., Li Y. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats. Nanomedicine: Nanotechnology, Biology and Medicine. 2012;8(5):740-747.

     Not in our library10.1016/j.nano.2011.08.016 (opens in a new tab)

116. 116.
     Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation · 2016

     No notice
117. 117.

     Chin L. Y., Tan J. Y. P., Choudhury H., Pandey M., Sisinthy S. P., Gorain B. Development and optimization of chitosan coated nanoemulgel of telmisartan for intranasal delivery: a comparative study. Journal of Drug Delivery Science and Technology. 2021;62(2021).

     Not in our library10.1016/j.jddst.2021.102341 (opens in a new tab)

118. 118.

     Teaima M. H., Yasser M., Ahmed El-Nabarawi M., Ahmed Helal D. Proniosomal telmisartan tablets: formulation, in vitro evaluation and in vivo comparative pharmacokinetic study in rabbits. Drug Design, Development and Therapy. 2020;14:1319-1331.

     Not in our library10.2147/dddt.s245013 (opens in a new tab)

119. 119.

     Tang S. Y., Sivakumar M., Ng A. M. H., Shridharan P. Anti-inflammatory and analgesic activity of novel oral aspirin-loaded nanoemulsion and nano multiple emulsion formulations generated using ultrasound cavitation. International Journal of Pharmaceutics. 2012;430(1-2):299-306.

     Not in our library10.1016/j.ijpharm.2012.03.055 (opens in a new tab)

120. 120.

     Anuar N., Sabri A. H., Bustami Effendi T. J., Abdul Hamid K. Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability. Heliyon. 2020;6:7.

     Not in our library10.1016/j.heliyon.2020.e04570 (opens in a new tab)

121. 121.

     Sakeena M., Fa M., Za G., Mm K. Formulation and in vitro evaluation of ketoprofen in palm oil esters nanoemulsion for topical delivery. Journal of Oleo Science. 2010;59(4):223-228.

     Not in our library10.5650/jos.59.223 (opens in a new tab)

122. 122.

     Shakeel F. Criterion for excipients screening in the development of nanoemulsion formulation of three anti-inflammatory drugs. Pharmaceutical Development and Technology. 2010;15(2):131-138.

     Not in our library10.3109/10837450903055502 (opens in a new tab)

123. 123.

     Daar J., Khan A., Khan J., Khan A., Khan G. M. Studies on self-nanoemulsifying drug delivery system of flurbiprofen employing long, medium and short chain triglycerides. Pakistan journal of pharmaceutical sciences. 2017;30(2):601-606.

     Not in our library

124. 124.

     Göke K., Bunjes H. Drug solubility in lipid nanocarriers: influence of lipid matrix and available interfacial area. International Journal of Pharmaceutics. 2017;529(1-2):617-628.

     Not in our library10.1016/j.ijpharm.2017.07.025 (opens in a new tab)

125. 125.

     Hamed R., Mahmoud N. N., Alnadi S. H., Alkilani A. Z., Hussein G. Diclofenac diethylamine nanosystems-loaded bigels for topical delivery: development, rheological characterization, and release studies. Drug Development and Industrial Pharmacy. 2020;46(10):1705-1715.

     Not in our library10.1080/03639045.2020.1820038 (opens in a new tab)

126. 126.

     Alam M. S., Algahtani M. S., Ahmad J., et al. Formulation design and evaluation of aceclofenac nanogel for topical application. Therapeutic Delivery. 2020;11(12):767-778.

     Not in our library10.4155/tde-2020-0076 (opens in a new tab)

127. 127.

     Sindi A. M., Hosny K. M., Alharbi W. S. Lyophilized composite loaded with meloxicam-peppermint oil nanoemulsion for periodontal pain. Polymers. 2021;13(14):p. 2317.

     Not in our library10.3390/polym13142317 (opens in a new tab)

128. 128.

     Assali M., Zohud N. Design of multicomponent indomethacin‐paracetamol and famotidine loaded nanoparticles for sustained and effective anti‐inflammatory therapy. Drug Development Research. 2021;82(3):448-457.

     Not in our library10.1002/ddr.21768 (opens in a new tab)

129. 129.

     Motawea A., Borg T., Tarshoby M., Abd El-Gawad H. Nanoemulsifying drug delivery system to improve the bioavailability of piroxicam. Pharmaceutical Development and Technology. 2017;22(3):445-456.

     Not in our library10.1080/10837450.2016.1231810 (opens in a new tab)

130. 130.

     Abd E., Benson H., Mohammed Y., Roberts M., Grice J. Permeation mechanism of caffeine and naproxen through in vitro human epidermis: effect of vehicles and penetration enhancers. Skin Pharmacology and Physiology. 2019;32(3):132-141.

     Not in our library10.1159/000497225 (opens in a new tab)

131. 131.

     Smail S. S., Ghareeb M. M., Omer H. K., Al-Kinani O. A. A., Alany R. G. Studies on surfactants, cosurfactants, and oils for prospective use in formulation of ketorolac tromethamine ophthalmic nanoemulsions. Pharmaceutics. 2021;13(4):p. 467.

     Not in our library10.3390/pharmaceutics13040467 (opens in a new tab)

132. 132.

     Kumar R., Singh A., Garg N., Siril P. F. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs. Ultrasonics Sonochemistry. 2018;40:686-696.

     Not in our library10.1016/j.ultsonch.2017.08.018 (opens in a new tab)

133. 133.
     Nanoemulsion and Nanoliposome Based Strategies for Improving Anthocyanin Stability and Bioavailability · 2019

     No notice
134. 134.

     Solans C., Izquierdo P., Nolla J., Azemar N., Garcia-Celma M. J. Nano-emulsions. Current Opinion in Colloid and Interface Science. 2005;10(3-4):102-110.

     Not in our library10.1016/j.cocis.2005.06.004 (opens in a new tab)

135. 135.

     Primo F. L., Michieleto L., Rodrigues M. A., et al. Magnetic nanoemulsions as drug delivery system for Foscan®: skin permeation and retention in vitro assays for topical application in photodynamic therapy (PDT) of skin cancer. Journal of Magnetism and Magnetic Materials. 2007;311(1):354-357.

     Not in our library10.1016/j.jmmm.2006.10.1183 (opens in a new tab)

136. 136.

     Müller-Goymann C. C. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. European Journal of Pharmaceutics and Biopharmaceutics. 2004;58(2):343-356.

     Not in our library10.1016/j.ejpb.2004.03.028 (opens in a new tab)

137. 137.

     Khanna V., Singh S., Singh Baghel D., Kaur B., Nayar A., Ghimire R. Nanoemulsions–present and future perspective-an overview. Journal of Emerging Technologies and Innovative Research. 2018;5.

     Not in our library

138. 138.

     Thiagarajan P. Nanoemulsions for drug delivery through different routes. Research in Biotechnology. 2011;2.

     Not in our library

139. 139.

     Shakeel F., Ramadan W. Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloids and Surfaces B: Biointerfaces. 2010;75(1):356-362.

     Not in our library10.1016/j.colsurfb.2009.09.010 (opens in a new tab)

140. 140.

     Mansour H. M., Rhee Y. S., Wu X. Nanomedicine in pulmonary delivery. International Journal of Nanomedicine. 2009;4:299-319.

     Not in our library10.2147/ijn.s4937 (opens in a new tab)

141. 141.

     Liu F., Yang J., Huang L., Liu D. Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transfer. Pharmaceutical Research. 1996;13(11):1642-1646.

     Not in our library10.1023/a:1016480421204 (opens in a new tab)

142. 142.

     Yi S. W., Yune T. Y., Kim T. W., et al. A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system. Pharmaceutical Research. 2000;17(3):314-320.

     Not in our library10.1023/a:1007553106681 (opens in a new tab)

143. 143.

     Liu C.-H., Yu S.-Y. Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery. Colloids and Surfaces B: Biointerfaces. 2010;79(2):509-515.

     Not in our library10.1016/j.colsurfb.2010.05.026 (opens in a new tab)

144. 144.

     Bivas-Benita M., Oudshoorn M., Romeijn S., et al. Cationic submicron emulsions for pulmonary DNA immunization. Journal of Controlled Release. 2004;100(1):145-155.

     Not in our library10.1016/j.jconrel.2004.08.008 (opens in a new tab)

145. 145.

     Ganta S., Deshpande D., Korde A., Amiji M. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers. Molecular Membrane Biology. 2010;27(7):260-273.

     Not in our library10.3109/09687688.2010.497971 (opens in a new tab)

146. 146.

     Dhahir R. K., Al-Nima A. M., Al-Bazzaz F. Nanoemulsions as ophthalmic drug delivery systems. Turkish Journal of Pharmaceutical Sciences. 2021;18(5):652-664.

     Not in our library10.4274/tjps.galenos.2020.59319 (opens in a new tab)

147. 147.

     Pardridge W. M. Non-invasive drug delivery to the human brain using endogenous blood–brain barrier transport systems. Pharmaceutical Science and Technology Today. 1999;2(2):49-59.

     Not in our library10.1016/s1461-5347(98)00117-5 (opens in a new tab)

148. 148.

     Kumar M., Misra A., Babbar A. K., Mishra A. K., Mishra P., Pathak K. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. International Journal of Pharmaceutics. 2008;358(1-2):285-291.

     Not in our library10.1016/j.ijpharm.2008.03.029 (opens in a new tab)

149. 149.

     Mistry A., Stolnik S., Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. International Journal of Pharmaceutics. 2009;379(1):146-157.

     Not in our library10.1016/j.ijpharm.2009.06.019 (opens in a new tab)

150. 150.

     Csaba N., Garcia-Fuentes M., Alonso M. J. Nanoparticles for nasal vaccination. Advanced Drug Delivery Reviews. 2009;61(2):140-157.

     Not in our library10.1016/j.addr.2008.09.005 (opens in a new tab)

151. 151.

     Rinaldi F., Maurizi L., Forte J., et al. Resveratrol-loaded nanoemulsions: in vitro activity on human T24 bladder cancer cells. Nanomaterials. 2021;11(6):p. 1569.

     Not in our library10.3390/nano11061569 (opens in a new tab)

Cited by papers we hold 1

• Biodegradable nanomaterials in boosting seed vigor and germination: seed coating towards sustainability · 2025
  Not checked

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.